Lipa Pharmaceuticals v Jarouche

In the case of Lipa Pharmaceuticals v Jarouche, the dispute centred on the employment termination of Dr Jarouche by Lipa Pharmaceuticals. Dr Jarouche alleged that she had been constructively dismissed, while Lipa argued that she had resigned. The matter was brought before the Fair Work Commission and ultimately reached the Full Bench for determination of the key legal issues. The primary issue before the court was whether Dr Jarouche was dismissed by Lipa Pharmaceuticals or whether she resigned from her employment. The court needed to discern the true nature of the termination of Dr Jarouche's employment, considering the actions of both parties and the context in which they occurred.

The court found that the conduct of Mr Tanna, a representative of Lipa Pharmaceuticals, on 29 September 2022 and subsequent days clearly indicated an intention to terminate Dr Jarouche's employment. The court held that Dr Jarouche had no real choice other than to resign, as evidenced by the immediate cessation of her work and departure from the workplace following Mr Tanna's meeting with her. The court further clarified that although the exact terms of the departure were later negotiated, the fundamental decision to end Dr Jarouche's employment had already been made by Lipa Pharmaceuticals on 29 September 2022. The court determined that Dr Jarouche's acceptance of the proposed 'managed resignation' was a response to the already imposed reality of her employment termination.

In light of the findings, the court concluded that Dr Jarouche had been dismissed by Lipa Pharmaceuticals, within the meaning of section 386(1) of the Fair Work Act. This conclusion was based on the jurisdictional fact that Dr Jarouche's employment relationship had effectively ended on Lipa's initiative on 29 September 2022, despite the subsequent negotiations over the terms of her departure. The court upheld the decision of the Deputy President that Dr Jarouche had been dismissed and rejected Lipa's appeal.